Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

siRNA - Small Interfering RNAs

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...

RNA Interference

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Remotely monitored physical activity from older people with cardiac devices associates with physical functioning.

BMC geriatrics·2024

Same author

Photopolarographic Behavior of Inorganic Depolarizers.

Journal of research of the National Bureau of Standards. Section A, Physics and chemistry·2020

Same author

Safety of sedation for gastrointestinal endoscopy in a group of university-affiliated hospitals: a prospective cohort study.

British journal of anaesthesia·2017

Same author

Consensus and variations in opinions on delirium care: a survey of European delirium specialists.

International psychogeriatrics·2013

Same author

An evaluation of clinical stability criteria to predict hospital course in community-acquired pneumonia.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2013

Same author

Effect of reaction between mercury and oxygen upon polarographic waves of certain metals at small concentrations.

Journal of research of the National Bureau of Standards·2010

Same journal

Erratum to: Immunotherapeutic Approach to Cancer with Cutaneous DNA Vaccination.

Methods in molecular medicine·2015

Same journal

Methods for cancer gene therapy using tumor suppressor genes.

Methods in molecular medicine·2014

Same journal

Suppression of the human carcinoma phenotype by an antioncogene ribozyme.

Methods in molecular medicine·2014

Same journal

Methods for the use of stromal cells for therapeutic gene therapy.

Methods in molecular medicine·2014

Same journal

Methods for adenovirus-mediated gene transfer to synovium in vivo.

Methods in molecular medicine·2014

Same journal

Methods for gene transfer to synovium.

Methods in molecular medicine·2014

See all related articles

Search research articles

Related Experiment Video

Updated: May 25, 2026

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids

Published on: September 21, 2017

Antisense oligonucleotides as research tools.

J K Taylor¹, S R Cooper, N M Dean

¹Department of Pharmacology, Isis Pharmaceuticals, Carlsbad, CA.

Methods in Molecular Medicine

|February 11, 2012

Summary

This summary is machine-generated.

Antisense oligonucleotides (ASOs) offer a potent alternative to small molecule inhibitors for research and therapy. These DNA molecules target specific messenger RNA, effectively blocking protein production through well-understood mechanisms.

More Related Videos

Using Modified Synthetic Oligonucleotides to Assay Nucleic Acid-Metabolizing Enzymes

Using Modified Synthetic Oligonucleotides to Assay Nucleic Acid-Metabolizing Enzymes

Published on: July 5, 2024

Related Experiment Videos

Last Updated: May 25, 2026

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids

Published on: September 21, 2017

Using Modified Synthetic Oligonucleotides to Assay Nucleic Acid-Metabolizing Enzymes

Using Modified Synthetic Oligonucleotides to Assay Nucleic Acid-Metabolizing Enzymes

Published on: July 5, 2024

Area of Science:

Molecular Biology
Drug Discovery
Genetics

Background:

Small molecule inhibitors are widely used but have limitations.
Antisense oligonucleotides (ASOs) present a promising alternative.
ASOs function as targeted gene silencers.

Purpose of the Study:

To highlight the utility of ASOs in biological research.
To introduce ASOs as a therapeutic modality.
To explain the mechanism of action for ASO-mediated gene silencing.

Main Methods:

Designing chemically modified DNA oligonucleotides.
Utilizing hybridization to specific mRNA sequences.
Leveraging established mechanisms for gene silencing.

Main Results:

ASOs demonstrate efficacy as research tools.
ASOs show potential as therapeutic agents.
The interaction of ASOs with mRNA inhibits protein translation.

Conclusions:

ASOs are a powerful alternative to traditional inhibitors.
The application of ASOs spans both research and therapeutics.
ASO technology relies on specific mRNA targeting for gene regulation.